Therapeutic options for the management of severe COVID-19: A rheumatology perspective()

The novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). Acute respiratory distress syndrome (ARDS), multiorgan dysfunction and thrombotic events are among the leading causes of death in critically ill patients with COVID-19. The elev...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza-Pinto, Claudia, García-Carrasco, Mario, Munguía Realpozo, Pamela, Méndez-Martínez, Socorro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561336/
https://www.ncbi.nlm.nih.gov/pubmed/34625144
http://dx.doi.org/10.1016/j.reumae.2020.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561336/
https://www.ncbi.nlm.nih.gov/pubmed/34625144
http://dx.doi.org/10.1016/j.reumae.2020.05.002

Ejemplares similares